Most cancer-related problems are caused by metastasis via attachment-free cell growth and survival. Unfortunately there has been no effective agents preventing or delaying fundamental metastatic processes. We are developing a new therapeutic approach able to affect only metastatic cells growing in attachment-free condition. 

Our leading candidate "Drug D" is able to affect only cells growing in attachment-free condition (3D spheroid) while do nothing on the same cells growing in 2D monolayer.

This behavior differentiates from currently available anti-cancer therapeutics including small molecules and ADCs which tend to be more effective in 2D than 3D. 

The novel mechanism of action has a potential of overcoming drug resistance encountered with current anti-cancer therapeutics.